HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The antihypertensive property of NIP-121, a novel potassium channel opener in rats.

Abstract
The antihypertensive effects of NIP-121, a novel potassium channel opener, were examined in comparison with cromakalim and its active enantiomer, lemakalim. In experiments by direct blood pressure measurements, orally administered NIP-121 dose-relatedly decreased arterial blood pressure in conscious spontaneously hypertensive rats (SHRs), and the ED20 values (the doses to produce 20% decrease of the mean blood pressure) of NIP-121 and cromakalim were 0.010 and 0.11 mg/kg, respectively, NIP-121 thus being about ten times more potent than cromakalim. The duration of the hypotensive effect by NIP-121 was longer than that by cromakalim. The hypotensive effect of NIP-121 was stronger in SHRs than in normotensive rats. All three drugs showed tachycardia that was antagonized by a beta-blocker, propranolol. Intravenously administered NIP-121 also showed a more potent hypotensive action with longer duration than cromakalim in conscious SHRs. The ED20 values for hypotension by NIP-121, cromakalim, and lemakalim were 0.017, 0.040, and 0.016 mg/kg, respectively. The intravenous hypotensive potency of NIP-121 but not cromakalim was similar to that of p.o. administration. The repeated treatments with NIP-121 (0.025, 0.05, and 0.1 mg/kg p.o. once a day) for 15 days did not modify the degree of the hypotensive action. In the anesthetized SHRs, pretreatment with glibenclamide but not other antagonists (atropine, propranolol, diphenhydramine + cimetidine, or indomethacin) suppressed the decrease in blood pressure induced by NIP-121.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsY Masuda, C Arakawa, T Yokoyama, K Shigenobu, S Tanaka
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 18 Issue 2 Pg. 190-7 (Aug 1991) ISSN: 0160-2446 [Print] United States
PMID1717778 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antihypertensive Agents
  • Benzopyrans
  • Oxadiazoles
  • Piperidines
  • Potassium Channels
  • Pyrroles
  • Cromakalim
  • NIP 121
Topics
  • Administration, Oral
  • Animals
  • Antihypertensive Agents (pharmacology)
  • Benzopyrans (pharmacology)
  • Blood Pressure (drug effects)
  • Cromakalim
  • Dose-Response Relationship, Drug
  • Heart Rate (drug effects)
  • Injections, Intravenous
  • Male
  • Oxadiazoles (pharmacology)
  • Piperidines (pharmacology)
  • Potassium Channels (drug effects)
  • Pyrroles (pharmacology)
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred Strains
  • Rats, Inbred WKY
  • Species Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: